Abstract
Genetic predisposition to venous thrombosis and elevation in total homocysteine (HC) levels from mutations in the methylenetetrahydrofolate reductase (MTHFR) gene have been described as having roles in the pathogenesis of recurrent pregnancy loss (RPL). Although a serum HC level has been recommended as a screening test for MTHFR polymorphism in women with RPL, the value of this assay remains unclear. The purpose of this study was to determine the frequency of elevated HC levels in women with RPL, and to assess the association between HC levels and common MTHFR polymorphisms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
